JPMorgan Chase & Co’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-100,660
| Closed | -$1.02M | – | 6359 |
|
|
2022
Q4 | $1.02M | Sell |
100,660
-99,340
| -50% | -$1M | ﹤0.01% | 3339 |
|
|
2022
Q3 | $1.99M | Sell |
200,000
-1,816,756
| -90% | -$18M | ﹤0.01% | 2912 |
|
|
2022
Q2 | $20M | Buy |
+2,016,756
| New | +$20M | ﹤0.01% | 1438 |
|
|
2022
Q1 | – | Sell |
-50,000
| Closed | -$492K | – | 6126 |
|
|
2021
Q4 | $492K | Buy |
+50,000
| New | +$492K | ﹤0.01% | 4073 |
|